Table 2 Treatment outcome of MDR-TB patient notified between 2011 and 2013
Notification year | 2011 | 2012 | 2013 | 2011–2013 | |||
|---|---|---|---|---|---|---|---|
Evaluation year | End of 2013 | End of 2016 | End of 2014 | End of 2016 | End of 2015 | End of 2016 | End of 2016 |
Total (%) | 59 (100.0) | 59 (100.0) | 64 (100.0) | 64 (100.0) | 49 (100.0) | 49 (100.0) | 172 (100.0) |
Treatment completed | 32 (54.2) | 35 (59.3) | 30 (46.9) | 33 (51.6) | 25 (51.0) | 30 (61.2) | 98 (57.0) |
Treatment stopped (adverse effects) | 4 (6.8) | 4 (6.8) | 2 (3.1) | 2 (3.1) | 2 (4.1) | 2 (4.1) | 8 (4.7) |
Treatment stopped (other reasons) | 1 (1.7) | 1 (1.7) | 1 (1.6) | 1 (1.6) | 0 (0.0) | 0 (0.0) | 2 (1.2) |
Died (TB) | 9 (15.3) | 9 (15.3) | 7 (10.9) | 8 (12.5) | 5 (10.2) | 5 (10.2) | 22 (12.8) |
Died (non-TB) | 5 (8.5) | 5 (8.5) | 10 (15.6) | 10 (15.6) | 5 (10.2) | 5 (10.2) | 20 (11.6) |
Still on treatment | 4 (6.8) | 0 (0.0) | 6 (9.4) | 1 (1.6) | 5 (10.2) | 0 (0.0) | 1 (0.6) |
Transferred out | 4 (6.8) | 4 (6.8) | 5 (7.8) | 6 (9.4) | 7 (14.3) | 7 (14.3) | 17 (9.9) |
Unknown | 0 (0.0) | 1 (1.7) | 1 (1.6) | 1 (1.6) | 0 (0.0) | 0 (0.0) | 2 (1.2) |
Treatment not started | 0 (0.0) | 0 (0.0) | 2 (3.1) | 2 (3.1) | 0 (0.0) | 0 (0.0) | 2 (1.2) |